Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.

Journal of Neuro-oncology
Lina Marenco-HillembrandKaisorn L Chaichana

Abstract

Despite aggressive treatment with chemoradiotherapy and maximum surgical resection, survival in patients with glioblastoma (GBM) remains poor. Ongoing efforts are aiming to prolong the lifespan of these patients; however, disparities exist in reported survival values with lack of clear evidence that objectively examines GBM survival trends. We aim to describe the current status and advances in the survival of patients with GBM, by analyzing median overall survival through time and between treatment modalities. A systematic review was conducted according to PRISMA guidelines to identify articles of newly diagnosed glioblastoma from 1978 to 2018. Full-text glioblastoma papers with human subjects, ≥ 18 years old, and n ≥ 25, were included for evaluation. The central tendency of median overall survival (MOS) was 13.5 months (2.3-29.6) and cumulative 5-year survival was 5.8% (0.01%-29.1%), with a significant difference in survival between studies that predate versus postdate the implementation of temozolomide and radiation, [12.5 (2.3-28) vs 15.6 (3.8-29.6) months, P < 0.001]. In clinical trials, bevacizumab [18.2 (10.6-23.0) months], tumor treating fields (TTF) [20.7 (20.5-20.9) months], and vaccines [19.2 (15.3-26.0) months] repor...Continue Reading

References

Jul 12, 2001·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·M C HulshofD González González
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Eilon D KirsonYoram Palti
May 7, 2008·Journal of Neuro-oncology·Kaisorn L ChaichanaAlfredo Quinones-Hinojosa
Oct 10, 2009·Journal of Immunotherapy·Robert Owen DillmanMadeline Carol DePriest
Aug 11, 2010·Annals of Surgical Oncology·Kaisorn L ChaichanaAlfredo Quiñones-Hinojosa
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John H SampsonDarell D Bigner
May 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James J VredenburghHenry S Friedman
Nov 1, 2011·Journal of Neurosurgery·Ashwatha NarayanaMichael L Gruber
May 23, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roger StuppPhilip H Gutin
Oct 12, 2013·British Journal of Neurosurgery·Mario TeoJerome St George
Jan 5, 2014·PM & R : the Journal of Injury, Function, and Rehabilitation·Pamela S RobertsChirag G Patil
Feb 21, 2014·The New England Journal of Medicine·Mark R GilbertMinesh P Mehta
Feb 21, 2014·The New England Journal of Medicine·Olivier L ChinotTimothy Cloughesy
Jul 24, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jigisha P ThakkarJohn L Villano
Sep 23, 2014·JAMA Neurology·Alissa A ThomasAntonio M Omuro
Dec 17, 2015·JAMA : the Journal of the American Medical Association·Roger StuppZvi Ram
May 27, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roy RamplingJames W A Ritchie
Feb 1, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Renata UrsuAntoine F Carpentier
Mar 16, 2017·The New England Journal of Medicine·James R PerryUNKNOWN Trial Investigators
Oct 28, 2017·Current Oncology Reports·Kelly Braun, Manmeet S Ahluwalia
Jan 20, 2018·Journal of Neuro-oncology·Jonathan RickManish K Aghi
Apr 13, 2018·Nature Reviews. Clinical Oncology·Michael LimMichael Weller
Apr 20, 2018·Pharmacological Reviews·Andrea ShergalisNouri Neamati
May 29, 2018·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Tomasz Tykocki, Mohamed Eltayeb
Jul 28, 2018·World Neurosurgery·Alexander D RamosRohan Ramakrishna
Aug 28, 2018·World Neurosurgery·Mostafa FatehiBrian D Toyota
Sep 27, 2018·Asian Pacific Journal of Cancer Prevention : APJCP·Supapan WitthayanuwatSrichai Krusun
Oct 31, 2018·Frontiers in Oncology·Kewal K Jain
Feb 9, 2019·Nature Reviews. Clinical Oncology·Kenneth AldapeRichard J Gilbertson
Jun 25, 2019·Mayo Clinic Proceedings·J Nathan CantrellDaniel M Trifiletti

❮ Previous
Next ❯

Citations

Nov 13, 2020·Acta neurochirurgica·Zixiao YangWei Zhu
Dec 4, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christina C Huang, Marc S Mendonca
Nov 3, 2020·World Neurosurgery·Javier A JacoboSergio Moreno-Jimenez
Feb 19, 2021·Surgical Neurology International·Iuri Santana NevilleGuilherme Lepski
Mar 23, 2021·Frontiers in Immunology·Darel Martínez BedoyaDenis Migliorini
Apr 16, 2021·Journal of Neuro-oncology·Urban J ScheuringStefanie Tietze
Jun 3, 2021·Journal of Personalized Medicine·Andrea SalmaggiEmilio Ciusani
Jul 3, 2021·Tomography : a Journal for Imaging Research·Taejin L MinBrent D Weinberg
Aug 8, 2021·Cancers·Vincenzo Di NunnoAlba Ariela Brandes
Sep 10, 2021·Journal of Neuropathology and Experimental Neurology·Narges AhangariJohn Woulfe
Sep 21, 2021·Frontiers in Cell and Developmental Biology·Yan LiYiquan Ke
Sep 21, 2021·Experimental and Therapeutic Medicine·Nan WangYufei Gao
Nov 7, 2021·Journal of Experimental & Clinical Cancer Research : CR·Silvia MatteoniClaudia Abbruzzese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.